Jove
Visualize
Contact Us

Related Experiment Videos

Phototherapy and systemic treatments.

Nick J Reynolds1, Simon J Meggitt

  • 1Department of Dermatology, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH. n.j.reynolds@ncl.ac.uk

Hospital Medicine (London, England : 1998)
|December 12, 2002
PubMed
Summary

For moderate to severe atopic eczema uncontrolled by standard treatments, evidence for phototherapy and systemic therapies is reviewed. Randomized controlled trials are crucial due to significant placebo effects in clinical studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same author

Engineered Caf1 Constructs Encoding Laminin-332 Motifs: A Novel Approach for Enhanced Cutaneous Wound Healing.

The British journal of dermatology·2026
Same author

Serious infection risk with systemic treatments for psoriasis: A cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

The British journal of dermatology·2026
Same author

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Clinical and translational science·2026
Same author

Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis.

The British journal of dermatology·2026
Same author

Serious infection risk in people treated with infliximab for severe psoriasis.

The British journal of dermatology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Dermatology
  • Immunology
  • Clinical Trials

Background:

  • Moderate to severe atopic eczema significantly impacts patients' quality of life.
  • Current treatments like emollients and topical steroids are insufficient for a proportion of individuals.
  • High placebo response rates necessitate rigorous clinical trial designs.

Purpose of the Study:

  • To review existing evidence on phototherapy for atopic eczema.
  • To evaluate the efficacy of systemic treatments for moderate to severe atopic eczema.
  • To inform clinical practice and future research directions.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs).
  • Analysis of studies investigating phototherapy modalities (e.g., UVB, PUVA).

Related Experiment Videos

  • Assessment of evidence for systemic agents (e.g., immunosuppressants, biologics).

    • Main Results:

    • Phototherapy shows efficacy in reducing eczema severity and symptoms.
    • Systemic treatments demonstrate effectiveness in controlling severe atopic eczema.
    • Evidence quality varies across different treatment modalities.

    Conclusions:

    • Phototherapy and systemic treatments offer valuable options for refractory atopic eczema.
    • Further high-quality RCTs are needed to optimize treatment selection.
    • Personalized treatment strategies are essential for managing severe atopic eczema.